Packages (Simulation)
Reagent Preparation
Image (I)
Image (II)
Certificate
- Featured-Product
ELISA Kit for Low Density Lipoprotein (LDL)
- Product No.SEB107Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Range7.8-500ng/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 3.7ng/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 280
For more details, please contact local distributors! US$ 400 US$ 1800 US$ 3400 US$ 28000
Specificity
This assay has high sensitivity and excellent specificity for detection of Low Density Lipoprotein (LDL).
No significant cross-reactivity or interference between Low Density Lipoprotein (LDL) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Low Density Lipoprotein (LDL) and the recovery rates were calculated by comparing the measured value to the expected amount of Low Density Lipoprotein (LDL) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 90-98 | 94 |
EDTA plasma(n=5) | 89-96 | 92 |
heparin plasma(n=5) | 81-98 | 84 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Low Density Lipoprotein (LDL) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Low Density Lipoprotein (LDL) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Low Density Lipoprotein (LDL) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 96-103% | 90-101% | 80-95% | 86-102% |
EDTA plasma(n=5) | 88-95% | 78-92% | 88-99% | 87-104% |
heparin plasma(n=5) | 94-102% | 85-99% | 82-97% | 78-99% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.
GIVEAWAYS
INCREMENT SERVICES
Magazine | Citations |
PloS one | Atheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDL. NCBI: PMC3896367 |
PLoS One. | Atheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDL Pubmed:24465540 |
J Lipid Res | PCSK9 deficiency unmasks a sex-and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice PubMed: 26323289 |
Neuroscience | 27-Hydroxycholesterol contributes to disruptive effects on learning and memory by modulating cholesterol metabolism in the rat brain PubMed: 25987203 |
The Journal of Nutritional Biochemistry | Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice Pubmed:27142749 |
Journal of Functional Foods | Red paprika (Capsicum annuum L.) and its main carotenoid capsanthin ameliorate impaired lipid metabolism in the liver and adipose tissue of high-fat diet-induced obese mice S1756464617300555 |
Int J Mol Sci. | Combined Effects of Curcumin and Lycopene or Bixin in Yoghurt on Inhibition of LDL Oxidation and Increases in HDL and Paraoxonase Levels in Streptozotocin-Diabetic Rats. pubmed:28333071 |
Journal of Surgical Arts/Cerrahi Sanatlar Dergisi | THE FUNCTION OF SIALIC ACID AS A RADICAL SCAVENGER IN EXPERIMENTAL HYPOTHYROIDISM WITH AND WITHOUT HYPERLIPIDEMIA. Hiperlipidemili ve … 163 |
Journal of Functional Foods | Red paprika (Capsicum annuum L.) and its main carotenoid capsanthin ameliorate impaired lipid metabolism in the liver and adipose tissue of high-fat diet-induced obese mice 10.1016:j.jff.2017.01.044 |
Microvascular Research | Effects of insulin analogs as an add-on to metformin on cutaneous microcirculation in type 2 diabetic patients pubmed:28954218 |
Biochemical and Biophysical Research Communications | Oxidized low-density lipoprotein promotes osteoclast differentiation from CD68 positive mononuclear cells by regulating HMGB1 release pubmed:29146189 |
Journal of Nutritional Science and Vitaminology (Tokyo) | Anthocyanin Cyanidin-3-Glucoside Attenuates Platelet Granule Release in Mice Fed High-Fat Diets. pubmed:28978870 |
Environmental Science and Pollution Research | Bifenthrin exerts proatherogenic effects via arterial accumulation of native and oxidized LDL in rats: the beneficial role of vitamin E and selenium Pubmed: 30465240 |
American Journal of Translational Research | Alteration of circulating innate lymphoid cells in patients with atherosclerotic cerebral infarction Pubmed: 30662674 |
Nature Communications | ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy Pubmed: 31358770 |
Diabetes Metab Syndr Obes | ¡°Adjusting Internal Organs and Dredging Channel¡± Electroacupuncture Ameliorates Insulin Resistance in Type 2 Diabetes Mellitus by Regulating the Intestinal?¡ 34135611 |
Evid Based Complement Alternat Med | Effect of Acupoint Embedding on Serum Leptin and Hypothalamus Leptin Receptor Expression in Rats with Simple Obesity 34659432 |
Ecotoxicol Environ Saf | High-fat diet-induced aggravation of cardiovascular impairment in permethrin-treated Wistar rats 34224971 |
Int J Food Sci Nutr | Brown and golden flaxseed reduce intestinal permeability and endotoxemia, and improve the lipid profile in perimenopausal overweight women Pubmed:35311432 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
NPB107Hu01 | Native Low Density Lipoprotein (LDL) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB107Hu01 | Polyclonal Antibody to Low Density Lipoprotein (LDL) | WB; IHC; ICC; IP. |
LAB107Hu71 | Biotin-Linked Polyclonal Antibody to Low Density Lipoprotein (LDL) | WB; IHC; ICC. |
HEB107Hu | High Sensitive ELISA Kit for Low Density Lipoprotein (LDL) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SEB107Hu | ELISA Kit for Low Density Lipoprotein (LDL) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCB107Hu | CLIA Kit for Low Density Lipoprotein (LDL) | Chemiluminescent immunoassay for Antigen Detection. |
LMB107Hu | Multiplex Assay Kit for Low Density Lipoprotein (LDL) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
KSB107Hu01 | ELISA Kit DIY Materials for Low Density Lipoprotein (LDL) | Main materials for "Do It (ELISA Kit) Yourself". |